Stock LAVI LAVIPHARM S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Lavipharm S.A.

Equities

LAVI

GRS246003008

Delayed Athens S.E.
Other stock markets
 03:30:03 2024-07-08 EDT 		5-day change 1st Jan Change
0.862 EUR -1.49% Intraday chart for Lavipharm S.A. 0.00% +8.29%
02-28 Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi. CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LAVI Stock
  4. News Lavipharm S.A.
  5. Analyst Reco.